Insiders Morphic Holding, Inc.

Equities

MORF

US61775R1059

Market Closed - Nasdaq Other stock markets 03:59:48 2024-06-04 pm EDT			5-day change	1st Jan Change
30.55 ^USD	-0.33%		-0.73%	+5.78%

Jun. 04	Crystal Amber's Portfolio Company Wins US Regulatory Nod for Diabetes Device Study Amendment	MT
May. 21	Morphic Demonstrates Novel Real-Time Visualization of Small Molecule A4ß7 Inhibition of Gut-Trafficking Cells	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morphic Holding Names Simon Cooper as Chief Medical Officer	Mar. 19	MT
Morphic Therapeutic Appoints Simon Cooper as Chief Medical Officer	Mar. 19	CI
Morphic Holding, Inc. Announces Chief Executive Officer Changes	Nov. 03	CI
Morphic Holdings Inc. Announces Chief Executive Officer, Praveen Tipirneni Suffered an Emergent Medical Event and Taking Medical Leave of Absence	23-09-26	CI
Morphic Chief Executive to Take Medical Leave of Absence; Shares Slump After Hours	23-09-26	MT
Insider Sell: Morphic Holding	23-09-11	MT
Insider Sell: Morphic Holding	23-06-05	MT
Insider Buy: Morphic Holding	23-05-05	MT
Insider Sell: Morphic Holding	23-04-28	MT
Insider Sell: Morphic Holding	23-04-28	MT
Morphic Therapeutic Appoints Joanne Gibbons as Senior Vice President of Regulatory Affairs	22-05-18	CI
Morphic Holding, Inc. Announces Management Appointments	22-05-12	CI
Morphic Therapeutic Announces Management Appointments	22-04-06	CI
Morphic Holding, Inc. Announces the Resignation of Martin Edwards as Class II Director and reappointed as Class III Director	22-03-15	CI
Morphic Holding, Inc. Announces Retirement of Dr. Nilesh Kumar from the Board and Resign as Member of the Board and the Audit and Nominating and Governance Committees	22-02-24	CI
Morphic Holding, Inc. Announces the Resignation of Peter G. Linde as Chief Medical Officer	21-11-04	CI
Insider Sell: Morphic Holding	21-10-18	MT
Morphic Holding, Inc. Appoints Nisha Nanda to the Board of Directors	21-08-23	CI
Morphic Holding, Inc. Appoints Susannah Gray to Its Board of Directors and the Audit Committee of the Board of Directors	21-08-04	CI
Morphic Therapeutic Announces Board Changes	21-04-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Morphic Holding, Inc.

Equities

MORF

US61775R1059

Insiders

Filters